553 Identifying Adalimumab Cellular and Molecular Targets in Psoriasis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.561
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adalimumab in Psoriasis: How Much Is Enough?

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Determining Microbial Products and Identifying Molecular Targets in the Human Microbiome

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2014English

Adalimumab for the Treatment of Psoriasis

Health Technology Assessment
MedicineHealth Policy
2009English

A Chemoproteomic Method for Identifying Cellular Targets of Covalent Kinase Inhibitors

Genes and Cancer
Cancer ResearchGenetics
2016English

Cellular Targets for Angiotensin II Fragments: Pharmacological and Molecular Evidence

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2002English

Correction: Chemical Proteomics Approaches for Identifying the Cellular Targets of Natural Products

Natural Product Reports
BiochemistryOrganic ChemistryDrug Discovery
2016English

Benefits vs. Side Effects of Adalimumab Treatment in Psoriasis/Psoriatic Arthritis

The Journal of Medical Research
2017English

Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Anticancer Properties of Tocotrienols: A Review of Cellular Mechanisms and Molecular Targets

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy